β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?
Patrick N. A. Harris(The University of Queensland), David L. Paterson(The University of Queensland), Paul Anantharajah Tambyah(National University of Singapore)
Cited by 205
Related Papers
Antimicrobial Resistance in ESKAPE Pathogens
|Clinical Microbiology Reviews|2020|2k
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
The emerging threat of multidrug-resistant Gram-negative bacteria in urology
|Nature Reviews Urology|2015|367